Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant Jaundice
Distal Malignant Biliary Obstruction: A Prospective Randomised Trial Comparing Metal and Plastic Stents in Palliation of Symptomatic Jaundice
1 other identifier
interventional
100
1 country
1
Brief Summary
Background: When considering any malignancy with limited life expectancy, palliation and quality of life are paramount. Owing to the limited centres offering ERCP and endoscopic palliation in the South African state sector, patients often travel vast distances and spend large amounts of time away from family and social support structures, severely impairing their quality of life. Stent occlusion with resultant readmission to an ERCP accredited centre obviously compounds this problem. The hypothesis we propose to test is whether metal stents as a primary procedure result in better patency rates, are more cost effective and improve quality of life than plastic stents. We propose to do this by means of a randomised trial determining the best method of palliation for inoperable distal common bile duct malignancies in the South African context. Primary end-point Assessing the cost of metal versus plastic stenting in inoperable malignant distal common bile duct strictures in patients with expected survival of 3 months or more as palliation of symptomatic obstructive jaundice. Cost to be assessed in terms of hardware, hospital stay and readmissions for stent occlusion(patency) and complications Secondary end-point Assessing quality of life using a validated scoring system(EORTC QLQ 30) in patients receiving a metal or plastic biliary stent as definitive means of palliation of malignant obstructive jaundice Hypothesis to be tested Metal stents are superior to plastic stents in terms of patency, resulting in more cost effective palliation of inoperable malignant jaundice and better quality of life due to fewer stent occlusions/episodes of cholangitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jun 2007
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 5, 2008
CompletedFirst Posted
Study publicly available on registry
August 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedAugust 11, 2008
May 1, 2007
1.9 years
August 5, 2008
August 5, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall cost comparison of metal versus plastic stent in patients with limited life expectancy
6 months
Secondary Outcomes (1)
Quality of life assessment
6 months
Study Arms (2)
SEMS
ACTIVE COMPARATORSelf expanding metal stent compared to plastic stent. Both recognised forms of treatment for condition
Plastic stent
ACTIVE COMPARATORInterventions
Comparing plastic and metal stents
Eligibility Criteria
You may qualify if:
- Symptomatic jaundice secondary to malignant distal CBD stricture
- Contra-indication to resection (advanced disease/advanced age/poor surgical risk)
You may not qualify if:
- Hilar/proximal CBD obstruction
- ECOG performance status 3 or 4
- Duodenal obstruction
- Previous stent placement
- Inability to comply with follow-up
- Ascites and liver metastases
- Not possible to stent endoscopically
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groote Schuur Hospital
Cape Town, Western Cape, 7925, South Africa
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John M Shaw, FCS, MMed
University of Cape Town
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 5, 2008
First Posted
August 11, 2008
Study Start
June 1, 2007
Primary Completion
May 1, 2009
Study Completion
August 1, 2009
Last Updated
August 11, 2008
Record last verified: 2007-05